To explore the inhibitory effect of FYLM on tumor progression in vivo, we first constructed a xenograft mouse model harboring EGFR-Del19/T790M/C797S-mutant via subcutaneously inoculating LLC-triple mutant cells into C57BL/6J mice. The gene discussed is EGFR; the disease is neoplasm.